Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy

Diabetes Technology and Therapeutics

Volumn 12, Issue 3, 2010, Pages 201-205

  Halford, Jean ^a   Harris, Claudia ^b  

^a Rocky Mt Diabet Osteoporosis Ctr   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THIOACETAZONE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; INCIDENCE; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77249172209     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0121     Document Type: Article

References (11)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1991;329:977-986.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
3. Hirsch I, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181.
4. Allen IA, Griggs RC: Metabolic Brain Dysfunction in Systemic Disorders. Boston: Little, Brown, 1992.
5. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
6. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor; a randomized control trial. Diabetes Care 2006;29:44-50.
7. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana- Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
8. Kovatchev B, Clarke W: Continuous glucose monitoring (CGM) reduces risks for hypo- and hyperglycemia and glucose variability in T1DM and insulin treated T2DM [abstract]. Diabetes 2007;56:23A.
9. Bloomgarden D, Freeman J, DeRobertis E: Early patient and clinician experiences with continuous glucose monitoring. Diabetes Spectrum 2008;21:128-133.
10. Reach G: Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther 2008;10:69-80.
11. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.